Dr. Agarwal’s Health Care Limited has informed the stock exchanges regarding a recent update on its international expansion. Orbit Healthcare Services (Mauritius) Limited, a wholly owned subsidiary, has completed an investment of USD 2,00,000 for the subscription of shares in the newly incorporated Orbit Health Care ETH PLC.

Following this investment, Orbit Health Care ETH PLC has officially become a wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited and an indirect, step-down wholly owned subsidiary of Dr. Agarwal’s Health Care Limited. This move aligns with the company’s ongoing strategy to strengthen its global footprint beyond its domestic market.

Incorporated in 2010, Dr. Agarwal’s Health Care Limited is a prominent eye care service provider in India, offering a wide range of services including cataract and refractive surgeries, consultations, and eye care products. As of 2025, the company maintains a robust network of over 230 domestic facilities across 14 states and 4 union territories, alongside 19 international facilities in nine African countries. The company successfully launched its Initial Public Offering (IPO) in February 2025, raising funds to support debt repayment and general corporate objectives.

In the fiscal year 2025, the company demonstrated strong financial performance, with revenue growing to ₹1,711 crore, reflecting a robust compound annual growth rate (CAGR) supported by the addition of new centers and an increasing volume of surgeries. The company’s growth is further bolstered by a significant payor mix dominated by cash and insurance patients. Major institutional investors and entities have been involved with the company, including Arvon Investments, Claymore Investments (Mauritius), and Hyperion Investments, who were identified as selling shareholders during the company’s 2025 IPO process.